Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Functional study of NbMED10b in signaling pathway

PROVIDER: PRJNA872759 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21177925_1.fastq.gz	Fastqsanger.gz
	SRR21177925_2.fastq.gz	Fastqsanger.gz
	SRR21177926_1.fastq.gz	Fastqsanger.gz
	SRR21177926_2.fastq.gz	Fastqsanger.gz
	SRR21177927_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

E-GEOD-108912

Project description:Ethylene-independent Promotion of Photomorphogenesis by Cytokinin Requires a Functional Cytokinin and Light Signaling Pathway.

2020-04-14 | E-GEOD-108912 | ExpressionAtlas

Project description:The CPR5 signaling pathway

| PRJNA1091570 | ENA

Project description:Plastid retrograde signaling pathway

| PRJNA789312 | ENA

Project description:Plastid retrograde signaling pathway

| PRJNA1066297 | ENA

Project description:Hif-1 signaling pathway

| PRJNA631150 | ENA

A randomized, controlled, multicenter, phase I/II study of cetuximab plus irinotecan investigating the pharmacodynamics, genomics and -genetics as well as the safety and efficacy of a dose escalation schedule of cetuximab compared with the standard fixed dosing regimen in patients with irinotecan-resistant EGFR expressing metastatic colorectal cancer.

Project description:Primary objectives: To compare in skin biopsies the effects of an cetuximab dose escalation regimen on EGFR and downstream signaling pathway markers with those of the standard cetuximab regimen Primary endpoints: Expression of EGFR and markers for the downstream signalling pathways in normal skin expressed by means of percentage of stained cells and staining intensity. IHC staining will allow a semi quantitative analysis of protein markers of the EGFR related signalling pathway.

| 2515542 | ecrin-mdr-crc

Exclusion of Candidate Genes within Thrombin Signaling Pathway in Association with Atypical Equine Thrombasthenia in Thoroughbreds

Project description:Exclusion of Candidate Genes within Thrombin Signaling Pathway in Association with Atypical Equine Thrombasthenia in Thoroughbreds

2019-08-02 | PRJEB33757 | EVA

Dynamic study of the cell wall integrity signaling pathway in Aspergillus nidulans

Project description:Dynamic study of the cell wall integrity signaling pathway in Aspergillus nidulans

| PRJNA562694 | ENA

The mutational characterization of adenoid cystic carcinoma

Project description:<p>Adenoid cystic carcinoma (ACC) typically emanate from the major and minor salivary glands of the head and neck. ACCs have high rates of perineural invasion, locoregional recurrence, and distant metastasis. Here we report sequencing of 60 tumor/normal pairs and find substantial mutational diversity. On pathway analysis, a significant percentage of mutations involved chromatin remodeling, DNA damage, protein kinase A signaling, and FGF/IGF/PI3K signaling. Whole genome sequencing and FISH confirmed the MYB-NFIB translocation as the main structural variant in ACC. Evaluation of potential driver mutations KDM6A and PIK3CA reveal that specific, observed alterations impart functional consequences. Collectively, our data delineate the ACC mutational landscape and establish a molecular foundation for investigating new therapies for this disease.</p>

| phs000612 | dbGaP

H014: HES5 mediates NOTCH signaling by interaction with AKT to drive liver carcinogenesis

Project description:Notch signaling plays a pivotal role in liver development and aberrant Notch signaling may lead to hepatocellular (HCC) or cholangiocellular carcinoma (CCA) development. Using whole exome sequencing of 54 human HCC samples, we discovered 19 somatic missense mutations in 15 different Notch pathway genes affecting 24.6% (14 of 57) of patients. Prediction of functional impact of these Notch pathway mutations revealed HES5-R31G to have high relevance. We found HES5 to be strongly activated by Notch signaling. In vitro, HES5 reduced cell migration and clonogenicity and in vivo, HES5 inhibited MYC-dependent liver tumor formation. But together with AKT, HES5 increased liver tumor formation in a mouse model. HES5 directly binds to AKT and AKT expression leads to increase HES5 protein levels. Furthermore, HES5 exhibits a negative feed-back loop by inhibiting NOTCH1 and HES1 gene expression. In contrast, HES5-R31G appears to be non-functional possibly by loss of nuclear translocation

| EGAS00001003329 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data